We came across a bullish thesis on Moderna, Inc. (MRNA) on Substack by Natan. In this article, we will summarize the bulls’ thesis on MRNA. Moderna, Inc. (MRNA)'s share was trading at $42.05 as of Nov 26th. MRNA’s trailing P/E was 7.06 according to Yahoo Finance.
[caption id="attachment_1000362" align="aligncenter" width="768"]Moderna, a biotech leader renowned for its groundbreaking mRNA technology, has faced significant challenges in recent years, with its stock declining 92% from its peak and revenue dropping by 50% in 2024 to...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.